SKYE — Skye Bioscience Share News
0.000.00%
Last trade - 00:00RCS - Redx Pharma Limited - Redx Announces ROCKETEER Phase 2 Trial for RXC008
Brief: Skye Bioscience Says John Sharp Resigns As CFO - SEC Filing
Brief: Skye Bioscience - Enters $22 Million Securities Purchase Agreement With Redmile Biopharma Investments Iii - SEC Filing
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
NASDAQ RESUMED AT 10:05 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:00 AM
NASDAQ RESUMED AT 10:00 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 09:36 AM
NASDAQ RESUMED AT 09:36 AM
NASDAQ RESUMED AT 09:31 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 09:31 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 09:00 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:39 AM
Skye Bioscience Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Skye Announces Cohort Review Committee Approved Opening Of Cohort 2 Based On Favorable Safety Data From First Four Participants Treated In Cohort 1
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis